UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 1,274,238 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 328.6% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,661,964 shares of the real estate investment trust’s stock after buying an additional 1,274,238 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Omega Healthcare Investors were worth $67,642,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Price T Rowe Associates Inc. MD lifted its stake in shares of Omega Healthcare Investors by 2.7% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 133,166 shares of the real estate investment trust’s stock valued at $4,218,000 after purchasing an additional 3,466 shares during the period. Tidal Investments LLC raised its holdings in Omega Healthcare Investors by 2.5% in the first quarter. Tidal Investments LLC now owns 14,325 shares of the real estate investment trust’s stock worth $454,000 after purchasing an additional 348 shares in the last quarter. Cetera Investment Advisers lifted its position in Omega Healthcare Investors by 170.6% during the first quarter. Cetera Investment Advisers now owns 97,866 shares of the real estate investment trust’s stock valued at $3,099,000 after buying an additional 61,700 shares during the period. Cetera Advisors LLC bought a new stake in shares of Omega Healthcare Investors during the 1st quarter valued at $646,000. Finally, GAMMA Investing LLC grew its position in shares of Omega Healthcare Investors by 93.4% in the 2nd quarter. GAMMA Investing LLC now owns 2,446 shares of the real estate investment trust’s stock worth $84,000 after buying an additional 1,181 shares during the period. 65.25% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on OHI shares. Scotiabank boosted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Royal Bank of Canada boosted their price target on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th. Wells Fargo & Company restated an “overweight” rating and issued a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective for the company in a research note on Thursday, October 31st. Finally, Berenberg Bank began coverage on Omega Healthcare Investors in a report on Friday, October 18th. They issued a “buy” rating and a $45.00 target price on the stock. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $40.00.

Omega Healthcare Investors Stock Down 2.0 %

OHI stock opened at $39.81 on Tuesday. The stock has a market capitalization of $10.75 billion, a P/E ratio of 29.27, a P/E/G ratio of 1.26 and a beta of 0.99. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $44.42. The business has a fifty day moving average price of $40.59 and a 200-day moving average price of $37.46.

Omega Healthcare Investors Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 6.73%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is 197.06%.

Insider Buying and Selling at Omega Healthcare Investors

In other news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.